2026 · 13 min read
The corporate consolidation of UK dentistry is no longer a trend and instead has become a structural reality. The largest dental corporates now operate hundreds of practices each, private equity continues to back aggressive acquisition strategies across the sector, and the pipeline of motivated corporate buyers has never been deeper or better funded. For dental practice owners considering an exit, the opportunity to achieve a strong valuation through a corporate sale is genuinely significant.
Though significant opportunity and straightforward process are not always the same thing. Selling your dental practice to a corporate is one of the most complex transactions a business owner in the healthcare sector will ever undertake and the stakes are high enough that the quality of your preparation, plus the calibre of your adviser, will determine whether you achieve a premium outcome or leave a material sum on the table.
At CorporateFinanceAdviser.co.uk we have pulled together this guide to cover everything a UK dental practice owner needs to understand and consider before entering a corporate sale process: how corporates value practices, what they look for, where the risks lie, and why in the context of corporate finance vs brokers, do independent corporate finance advisers consistently deliver better outcomes.
Why Corporates Are Buying and What That Means for You as a Seller
Understanding why corporates acquire dental practices is the foundation for positioning your practice effectively in a sale process. Corporates are not buying practices out of altruism or sector passion. They are executing a financial and operational strategy, and every acquisition must meet specific criteria within that strategy.
The primary corporate acquisition rationale is consolidation economics. A corporate operating 200 practices can negotiate laboratory contracts, equipment supply agreements, insurance arrangements, and software licensing at a scale that an independent practice owner simply cannot come close to matching.
Each new acquisition plugs into that infrastructure and benefits from those economies almost immediately. For a highly sought after practice, a corporate buyer maybe willing to pay not just a multiple of your earnings, but what it will may earn within their cost structure.
The secondary rationale, for PE (Private-Equity) backed groups in particular, is platform building. A corporate backed by private equity is itself building toward an exit, typically a sale to a larger group or a public listing within three to seven years. Every high-quality acquisition adds to the platform’s earnings base and its attractiveness to future buyers. This creates a motivated, well-funded buyer who is thinking about your practice not just in isolation but as a component of something much larger.
For you as a seller, this means two things. First, the right corporate buyer may genuinely attribute more value to your practice than its standalone earnings would suggest, particularly if your location, patient base, or associate structure fills a strategic gap in their portfolio. Second, the corporate’s adviser and deal team are well experienced, resourced, and solely negotiating in the corporate’s interest. You need someone equally experienced and resourced negotiating in yours, and it’s essential you take the appropriate steps to avoid unqualified advisers.
How Corporates Value Dental Practices
The valuation methodology applied by dental corporates has evolved considerably as the sector has matured, and understanding it is essential before you enter any negotiation.
The EBITDA Multiple
The primary valuation methodology for practices above a certain revenue threshold is a multiple of adjusted EBITDA – earnings before interest, taxes, depreciation, and amortisation, normalised for owner-specific costs and non-recurring items. Corporates in the current market are paying multiples broadly in the range of 5x to 9x adjusted EBITDA for dental practices, with the most strategically attractive practices achieving above this range in competitive processes.
The multiple applied to your specific practice is not fixed – it is a function of the quality of your earnings, the strategic relevance of your practice to the buyer, and the competitive dynamics of your sale process. A practice sold to a single corporate without competitive tension will almost always achieve a lower multiple than the same practice sold through a process that involves multiple motivated buyers.
If you’re not familiar with EBITDA, and particularly your Adjusted EBITDA, we strongly recommend checking out our blog Adjusted EBITDA Explained: The Addbacks and Takebacks Every Business Owner Must Understand Before Selling.
NHS Contract Value
For mixed or predominantly NHS practices, the value of your NHS contract, measured in units of dental activity (UDAs), is a central valuation input. Corporates acquiring NHS practices are buying contracted, recurring government-backed revenue, which they value highly. The UDA rate achieved, the sustainability of your contract delivery, and any recent clawback history will all be scrutinised carefully. Demonstrating consistent, full contract delivery without persistent clawback is one of the most important things an NHS practice owner can do in the period before a sale.
Private Revenue Quality
For private or mixed practices, the composition of private revenue matters enormously. Recurring treatments, hygiene programmes, and membership plan income are valued more highly than one-off or episodic treatments because they represent predictable, contractual cash flows. A practice with 400 active membership plan patients has structurally more defensible private revenue than a practice with equivalent gross income driven by irregular cosmetic treatments. Corporates will analyse this mix in detail, and it directly influences the multiple they are prepared to pay.
Associate Structure and Clinical Dependency
If a significant proportion of your practice revenue is generated by the principal owner, particularly if you are the primary clinical producer, corporates will factor in the transition risk. A practice where the principal does 60% of the clinical work and takes that revenue with them when they leave is a fundamentally different proposition to one where associates generate the majority of income. Reducing principal clinical dependency ahead of a sale, by building a strong associate team and transferring patient relationships where possible, directly addresses this concern and supports a higher valuation.
Property
Whether your practice premises are owned freehold, held on a long leasehold, or occupied on a short commercial lease affects both the valuation and the structure of the transaction. Freehold ownership is an asset that certain buyers will pay a premium for. Others will prefer to lease the premises from you post-completion, creating an ongoing income stream through a sale-and-leaseback arrangement. The right approach depends on your circumstances and tax position, and structuring this element of the transaction correctly can make a material difference to your total proceeds.
If you’re a little unsure as to what your dental practice may be worth, then consider our free valuation service.
What Corporates Look for During Due Diligence
Corporate acquirers conduct thorough due diligence on dental practice acquisitions. Understanding what they will examine and ensuring you are well prepared is the difference between a smooth process that completes at the agreed price and a protracted one where post-diligence price reductions erode your valuation.
Financial Due Diligence
The corporate’s financial advisers will conduct a quality of earnings analysis, reconciling your adjusted EBITDA back to underlying accounts and stress-testing every adjustment. They will examine revenue by treatment type, by associate, and by payment source. They will review your NHS contract performance in detail if applicable. They will look at working capital requirements, debtor days, and cash conversion. Anything inconsistent, unexplained, or inadequately documented will be flagged as a risk, and risks ultimately become price chips in the negotiation.
Clinical and Regulatory Due Diligence
Your CQC registration, inspection history, and compliance position will be reviewed. Any enforcement actions, warning notices, or conditions on your registration will create buyer concern. Your associates’ performer numbers, indemnity arrangements, and contractual status will be examined. Equipment maintenance records, infection control documentation, and health and safety compliance will all be part of the review.
Employment and HR Due Diligence
TUPE regulations apply to most dental practice sales, meaning your employees transfer to the corporate with their existing terms and conditions protected. The corporate will review all employment contracts, identify any legacy arrangements or potential claims, and assess pension obligations. Associates will be reviewed separately – the corporate will want to understand the contractual basis of each associate relationship and assess their likelihood of remaining post-completion.
NHS Contract Due Diligence
For NHS practices, the corporate will conduct detailed analysis of your NHS contract, including UDA delivery history, clawback exposure, and the terms and renewal status of your contract. They will also assess the CQC registered location status and the implications for contract continuity post-completion.
The Pre-Sale Checklist: What to Address Before You Approach a Corporate
We pulled together a basic summary check list as a practical foundation of your sale preparation. Work through each item honestly. The idea here is to help you refine your thoughts, and perhaps highlight gaps in your knowledge, which is perfectly normal. The gaps you identify are the areas where preparation work – ideally 12 to 24 months before your target sale date – will deliver the greatest return.
Remember, if engaging an adviser – make sure to check their background, actual academic credentials, and deals done.
Financial Preparation
Three years of practice accounts are available, internally consistent, and reconcile to tax returns
You have moved to reviewed or audited accounts, or can do so before the process launches
You have prepared a full adjusted EBITDA schedule with documented, defensible addbacks for owner salary above market rate, personal expenses, non-recurring costs, and any other normalisation items
Revenue is clearly segmented by treatment type, payment source, and associate, and this data is available for at least three years
NHS contract UDA delivery is consistent and clawback exposure is minimal and documented
Membership plan and hygiene programme income is clearly identified and its contractual basis is documented
Working capital position is understood and any significant debtor balances are explained
Any related party transactions – rent paid to a connected landlord, services from associated entities – are identified and can be explained clearly
Clinical and Regulatory Preparation
CQC registration is current, unrestricted, and reflects the current registered manager and location
Most recent CQC inspection resulted in a Good or Outstanding rating, or any Requires Improvement findings have been addressed and evidenced
All associates hold current performer numbers and their indemnity arrangements are documented
Equipment service and maintenance records are complete and up to date
Infection control policies and records meet current regulatory requirements
Health and safety documentation is current and accessible
Any historic CQC concerns, enforcement actions, or conditions are documented with evidence of resolution
NHS Contract Preparation
NHS contract documentation is located and accessible, including the original contract and any variations
UDA delivery history for the last three years is prepared and shows consistent delivery without material clawback
Any ongoing clawback disputes or contract performance concerns are identified and have a clear resolution narrative
The contract renewal position is understood and any upcoming renewal dates are flagged
The implications of a share sale versus asset sale for NHS contract continuity have been assessed with appropriate legal advice
Associate and Staffing Preparation
All associate agreements are in writing, current, and reflect the actual working arrangements in place
Associate performer numbers, indemnity status, and appraisal records are documented
Key associates have been identified and an assessment made of their likelihood to remain post-sale
All employment contracts for non-clinical staff are in writing and up to date
Any TUPE liabilities, historic HR disputes, or potential employment claims are identified and assessed
Pension arrangements are documented and any auto-enrolment obligations are being met
Property and Premises Preparation
If freehold, the title is clean, unencumbered, and any outstanding mortgage position is understood
If leasehold, the lease document is located and the remaining term, rent review provisions, and any landlord consent requirements for assignment are understood
A decision has been made – with appropriate tax and legal advice – on whether to include property in the sale or pursue a sale-and-leaseback structure
Any material dilapidations obligations under a lease have been assessed
Planning position for the premises is understood, including any restrictions relevant to dental use
Commercial and Operational Preparation
Principal clinical dependency has been assessed – ideally the principal generates no more than 30 to 40% of total practice revenue
Patient base is documented, including active patient numbers, recall rates, and new patient flow
Key supplier and laboratory relationships are documented and transferable
Practice management software data is well maintained and exportable for buyer review
Any key person dependencies beyond the principal – a practice manager or lead associate whose departure would be disruptive – have been identified and mitigated where possible
Personal and Tax Preparation
You have taken independent legal advice on the sale structure – share sale versus asset sale – and understand the tax implications of each
Your personal tax position, including entrepreneur’s relief (now Business Asset Disposal Relief) eligibility, has been reviewed and any planning undertaken
If you intend to remain involved post-completion in a clinical or consultancy capacity, the terms of that arrangement have been considered and are not prejudicial to your tax position
You have considered the implications of any deferred consideration or earnout structure and taken advice on how these are taxed
Why the Corporate’s Offer Is Not the Starting Point – It’s the Opening Position
This is perhaps the most important thing a dental practice owner can understand before entering a corporate sale process.
When a corporate approaches you directly, whether through a letter, a phone call, or a chance conversation at a conference, their initial offer is not a reflection of what your practice is worth. It is a reflection of what they hope to pay. Corporates approach practice owners directly precisely because a one-to-one negotiation, without competitive tension and without experienced adviser representation, consistently produces outcomes that favour the buyer.
The corporate’s deal team has completed dozens, sometimes hundreds, of acquisitions. They know exactly how to structure an approach that feels flattering and straightforward while anchoring the valuation at a level that serves their financial model. They know which levers to pull during due diligence to justify post-offer price reductions. And they know that a practice owner negotiating alone, without comparable transaction data or sector-specific advisory support, is at a structural disadvantage.
The solution is not to refuse direct approaches, it is to respond to them from a position of preparation and representation. An independent corporate finance adviser who knows the sector, knows the buyers, and has current transaction data will tell you immediately whether the approach on the table is at, below, or above where the market should be, and will structure a response that either improves the terms or creates the competitive dynamic needed to do so.
The Case for Running a Competitive Process
The single most effective mechanism for maximising your sale price is competitive tension. When a corporate knows they are one of several motivated bidders, their behaviour changes materially. Price increases. Conditions loosen. Timelines sharpen. The dynamic shifts from buyer-led to seller-led, and that shift is worth real money.
Creating genuine competitive tension requires knowing which corporates are most actively acquiring in your region right now, which ones would attribute the greatest strategic value to your specific practice, and how to approach them simultaneously and confidentially in a way that signals credibility and urgency. This is not a process that a practice owner can run effectively alone, and it is not something a generalist broker with a passive listings model is equipped to deliver.
An independent corporate finance adviser builds and executes this process as a core part of their service. The resulting competitive dynamic, even among just two or three genuinely motivated bidders, consistently generates outcomes that exceed the initial direct approach by a margin that more than justifies the advisory fee.
Selling in Leeds, Manchester, London, Birmingham, Wales, and Beyond: Does Location Matter?
The short answer is yes, but perhaps not in the way you might expect. The most acquisitive dental corporates operate nationally and will acquire in virtually any UK geography. However, certain locations carry strategic premium for certain buyers. A practice in an underserved urban area, a high-footfall commuter location, or a geography where a specific corporate is seeking to build density may command additional value above what the standalone financials would suggest.
Understanding which buyers attribute premium value to your specific location, and positioning your practice accordingly in the sale process, is part of the advisory work that generates above-market outcomes. A corporate finance adviser with current sector relationships will know which groups are prioritising which geographies at any given moment, and will structure your process to maximise the interest of those most likely to compete aggressively for your practice.
How We Support Dental Practice Owners Through a Corporate Sale
Our corporate finance team works with dental practice owners at every stage of the sale process, from initial valuation assessment through to completion.
Exit Readiness and Valuation Assessment – We review your current financial and operational position, identify the adjustments that will maximise your adjusted EBITDA, and give you a realistic, evidence-based view of what your practice is worth in the current market and what a well-structured sale process could realistically achieve.
Sale Preparation – We work with you through the preparation phase to address the items on the pre-sale checklist, strengthen your financial documentation, and build the information package that will be presented to buyers. This includes your adjusted EBITDA schedule, your information memorandum, and any financial models buyers will use to underwrite their offer.
Buyer Identification and Outreach – We identify the specific corporates and other buyers most likely to compete for your practice, approach them confidentially with appropriate non-disclosure protections, and manage the information flow throughout the process.
Offer Evaluation and Negotiation – When offers arrive, we evaluate them not just on headline price but on deal structure, deferred consideration, earnout provisions, property treatment, and all other terms that affect your actual net proceeds. We negotiate in your interest – not to close a deal quickly, but to close the right deal.
Due Diligence Support – We manage the due diligence process on your behalf, coordinating with your legal and accountancy advisers, responding to buyer information requests, and ensuring that the process does not become an opportunity for post-offer price renegotiation.
Request Your Free Dental Practice Valuation
If you are considering selling your dental practice to a corporate – whether your timeline is months or years – the most valuable step you can take today is understanding what your practice is genuinely worth in the current market, and what an independent, well-structured sale process could achieve for you.
We provide a free, no-obligation valuation assessment for dental practice owners across the UK, including Leeds, Manchester, London, Birmingham, Wales, and all surrounding regions. There is no listing fee, no pressure, and no obligation to proceed.
Frequently Asked Questions
What multiples are dental corporates paying? Recent EBITDA multiples for UK dental practices range broadly from 5x to 9x, with strategically attractive practices in competitive processes achieving above this range. The multiple is driven by earnings quality, NHS contract position, associate structure, private revenue mix, and the strategic relevance of the practice to the acquiring corporate. A free valuation assessment will give you a specific view of where your practice sits.
Should I respond to a direct approach from a corporate? Yes – but not without independent advice. A direct approach from a corporate is a positive signal of interest, but the terms of that approach will almost always be the opening position in a negotiation rather than a reflection of true market value. Taking initial independent advice before you respond costs nothing and could be worth a significant sum.
What is the difference between selling to a corporate and selling to an independent buyer? Corporates typically pay higher multiples than independent buyers because they are acquiring practices at scale and benefit from operational synergies. However, the process is more complex, due diligence is more rigorous, and the terms of the deal – particularly around deferred consideration and earnouts – require careful scrutiny. Independent buyers may offer simpler structures but typically cannot match the financial capacity of a well-funded corporate.
Will I have to stay on after the sale? Most corporates require the selling principal to remain in a clinical capacity for a transitional period, typically 12 to 24 months. The terms of this arrangement – remuneration, hours, clinical autonomy, and the treatment of any deferred consideration tied to post-completion performance – are an important part of the negotiation and should be reviewed carefully before heads of terms are agreed.
Can you help with practices in Leeds, Manchester, Birmingham, London, and Wales specifically? Yes – we work with dental practice owners across the UK regardless of location. Our buyer relationships cover the full range of nationally and regionally active corporates, and we have advised on transactions in all major UK regions. Location-specific knowledge of the active buyers in your area is part of the service we provide.